Personal tools

Coexpression cluster:C274: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
(Created page with "{{Coexpression_clusters |full_id=C274_CD14_Mast_immature_Basophils_mature_vagina_Hepatocyte |id=C274 }}")
 
No edit summary
Line 1: Line 1:
{{Coexpression_clusters
{{Coexpression_clusters
|full_id=C274_CD14_Mast_immature_Basophils_mature_vagina_Hepatocyte
|full_id=C274_CD14_Mast_immature_Basophils_mature_vagina_Hepatocyte
|gostat_on_coexpression_clusters=GO:0006903!vesicle targeting!0.00871164714386449!8773$GO:0051650!establishment of vesicle localization!0.00871164714386449!8773$GO:0051648!vesicle localization!0.00871164714386449!8773$GO:0006892!post-Golgi vesicle-mediated transport!0.0100167719467249!8773$GO:0051656!establishment of organelle localization!0.0100167719467249!8773$GO:0051640!organelle localization!0.0100691349978272!8773$GO:0019717!synaptosome!0.0100691349978272!8773$GO:0006944!membrane fusion!0.0100691349978272!8773$GO:0048193!Golgi vesicle transport!0.0215127152599617!8773
|id=C274
|id=C274
}}
}}

Revision as of 17:38, 18 May 2012


Full id: C274_CD14_Mast_immature_Basophils_mature_vagina_Hepatocyte



Phase1 CAGE Peaks

Hg19::chr10:134775979..134775984,+p@chr10:134775979..134775984
+
Hg19::chr11:63298876..63298880,-p@chr11:63298876..63298880
-
Hg19::chr11:65951241..65951245,-p@chr11:65951241..65951245
-
Hg19::chr12:104356528..104356534,+p@chr12:104356528..104356534
+
Hg19::chr12:1704684..1704694,+p@chr12:1704684..1704694
+
Hg19::chr12:31890320..31890327,-p@chr12:31890320..31890327
-
Hg19::chr12:52427143..52427164,+p@chr12:52427143..52427164
+
Hg19::chr12:7009390..7009406,+p@chr12:7009390..7009406
+
Hg19::chr13:31736341..31736352,+p@chr13:31736341..31736352
+
Hg19::chr13:75902777..75902790,-p@chr13:75902777..75902790
-
Hg19::chr14:65634137..65634143,+p@chr14:65634137..65634143
+
Hg19::chr14:93799634..93799654,-p5@BTBD7
Hg19::chr15:42787452..42787465,+p3@SNAP23
Hg19::chr16:31398258..31398263,+p@chr16:31398258..31398263
+
Hg19::chr17:72267455..72267461,-p@chr17:72267455..72267461
-
Hg19::chr18:77905923..77905938,+p1@LOC100130522
Hg19::chr19:2678248..2678258,-p@chr19:2678248..2678258
-
Hg19::chr19:54828407..54828412,+p@chr19:54828407..54828412
+
Hg19::chr19:7643171..7643177,-p@chr19:7643171..7643177
-
Hg19::chr19:9906796..9906801,-p@chr19:9906796..9906801
-
Hg19::chr1:12207060..12207069,+p@chr1:12207060..12207069
+
Hg19::chr1:173183104..173183105,+p@chr1:173183104..173183105
+
Hg19::chr1:212661739..212661745,-p@chr1:212661739..212661745
-
Hg19::chr20:17891803..17891806,+p@chr20:17891803..17891806
+
Hg19::chr20:2189294..2189298,+p@chr20:2189294..2189298
+
Hg19::chr20:47526947..47526954,-p@chr20:47526947..47526954
-
Hg19::chr20:49087009..49087016,-p@chr20:49087009..49087016
-
Hg19::chr21:45626767..45626771,+p@chr21:45626767..45626771
+
Hg19::chr22:25403779..25403785,+p@chr22:25403779..25403785
+
Hg19::chr2:242786344..242786355,+p5@ENST00000442867
Hg19::chr2:97232612..97232618,+p@chr2:97232612..97232618
+
Hg19::chr3:13493495..13493517,+p@chr3:13493495..13493517
+
Hg19::chr3:171812201..171812209,+p@chr3:171812201..171812209
+
Hg19::chr5:142147544..142147559,-p@chr5:142147544..142147559
-
Hg19::chr5:157026809..157026848,+p@chr5:157026809..157026848
+
Hg19::chr5:172199724..172199762,+p@chr5:172199724..172199762
+
Hg19::chr6:28222032..28222038,-p@chr6:28222032..28222038
-
Hg19::chr6:30755729..30755743,-p@chr6:30755729..30755743
-
Hg19::chr7:102336834..102336841,+p@chr7:102336834..102336841
+
Hg19::chr7:148224682..148224688,-p@chr7:148224682..148224688
-
Hg19::chr7:22867497..22867502,+p@chr7:22867497..22867502
+
Hg19::chr7:76803755..76803761,-p@chr7:76803755..76803761
-
Hg19::chr8:72754636..72754663,-p@chr8:72754636..72754663
-
Hg19::chr8:72754885..72754889,+p2@LOC100132891
Hg19::chr9:134516035..134516082,+p@chr9:134516035..134516082
+
Hg19::chr9:34986960..34986973,+p@chr9:34986960..34986973
+
Hg19::chrX:1441548..1441556,+p@chrX:1441548..1441556
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data

GO IDGO nameFDR corrected p-value
GO:0006903vesicle targeting0.00871164714386449
GO:0051650establishment of vesicle localization0.00871164714386449
GO:0051648vesicle localization0.00871164714386449
GO:0006892post-Golgi vesicle-mediated transport0.0100167719467249
GO:0051656establishment of organelle localization0.0100167719467249
GO:0051640organelle localization0.0100691349978272
GO:0019717synaptosome0.0100691349978272
GO:0006944membrane fusion0.0100691349978272
GO:0048193Golgi vesicle transport0.0215127152599617



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>

Cell Type
Ontology termp-valuen

Uber Anatomy
Ontology termp-valuen

Disease
Ontology termp-valuen


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data

No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data

"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=Coexpression_cluster:C274&oldid=1702871"